A novel mucosal orthotopic murine model of human papillomavirus-associated genital cancers

International Journal of Cancer

Volumn 128, Issue 9, 2011, Pages 2105-2113

  Decrausaz, Loane ^a   Gonçalves, Ana Rita ^a   Domingos Pereira, Sonia ^a   Pythoud, Christelle ^a   Stehle, Jean Christophe ^a   Schiller, John ^b   Jichlinski, Patrice ^a   Nardelli Haefliger, Denise ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cervical cancer; Genital tumor model; Human papillomavirus; Therapeutic vaccination

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; PROTEIN E6; PROTEIN E7; TRANSCRIPTION FACTOR FOXP3; WART VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER MODEL; CD8+ T LYMPHOCYTE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; FEMALE; GENITAL TRACT CANCER; HISTOPATHOLOGY; HUMAN PAPILLOMAVIRUS TYPE 16; IN VIVO STUDY; LYMPHATIC DRAINAGE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM; VAGINA CANCER; WART VIRUS;

ANIMALS; CARCINOMA, SQUAMOUS CELL; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; PAPILLOMAVIRUS INFECTIONS; TRANSPLANTATION, HETEROLOGOUS; UTERINE CERVICAL NEOPLASMS;

EID: 79952466306     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25561     Document Type: Article

References (27)

1. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006; 24(suppl 3):S11-25.
2. Lowy D, Schiller J. Prophylactic human papillomavirus vaccines. J Clin Invest 2006; 116:1167-73.
3. Timble CL, Frazer IH. Development of therapeutic HPV vaccines. Lancet Oncol 2009;10:975-80.
4. Kenter GG, Welters MJP, Valentijn ARPM, Lowik M, Berends-van der Meer DM, Vloon AP, Essahsah F, Fathers LM, Offringa R, Drijfhout JW, Wafelman AR, Oostendorp J, et al. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasis. N Engl J Med 2009;361:1838-47.
5. Mestecky J, Moldoveanu Z, Russell MW. Immunologic uniqueness of the genital tract: Challenge for vaccine development. Amer J Reprod Immunol 2005;53:208-14. (Pubitemid 40542802)
6. Revaz V, Nardelli-Haefliger D. The importance of mucosal immunity in defense against epithelial cancers. Curr Opin Immunol 2005;17:175-9. (Pubitemid 40343105)
7. Lin KY, Guarnieri FG, Staveleyocarroll KF, Levitsky HI, August JT, Pardoll DM, Wu TC. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 1996;56:21-6. (Pubitemid 26010379)
8. Revaz V, Debonneville A, Bobst M, Nardelli-Haefliger D. Monitoring of vaccine-specific gamma interferon induction in genital mucosa of mice by real-time reverse-transcription-PCR. Clin Vacc Immunol 2008;5:757-64. (Pubitemid 351967021)
9. Decrausaz L, Revaz V, Bobst M, Corthésy B, Romero P, Nardelli-Haefliger D. Induction of Human Papillomavirus oncogene-specific CD8 T cell effector responses in the genital mucosa of vaccinated mice. Int J Cancer 2010;126:2469-78.
10. Feltkamp MC, Smits HL, Vierboom MP, Minnaar RP, de JB, Drijfhout JW, ter SJ, Melief CJ, Kast WM. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol 1993;23: 2242-9. (Pubitemid 23265889)
11. Coles RM, Mueller SN, Heath WF, Carbone FR, Brooks AG. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus. J Immunol 2002;168:834-8. (Pubitemid 34049585)
12. Luci c, Hervouet C, Rousseau D, Holmgren J, Czerkinsky C, Anjuère F. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of Cholera Toxin. J Immunol 2006;176:2749-57.
13. Loskog A, Ninalga C, Hedlund T, Alimohammadi M, Malmström P, Tötterman T. Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy. Lab Anim 2005;4:384-93. (Pubitemid 41565459)
14. Roberts JN, CB B, CD T, Kines R, Bernardo M, Choyke PL, Lowy D, Schiller J. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med 2007;13:857-61. (Pubitemid 47038188)
15. Rodrigues JFT, Ferro EAV. Morphological changes in the vaginal epithelium during the oestrous cycle of calomys callosus (Rodentia. Cricetidae). Rev Bras Biol 1998; 58:527-39.
16. Wood CE, Chen Z, Cline JM, Miller BE, Burk RD. Characterization and experimental transmission of an oncogenic papillomavirus in female macaques. J Virol 2007;81:6339-45. (Pubitemid 46878040)
17. Murchison EP. Clonally transmissible cancers in dogs and Tasmanian devils. Oncogene 2008;suppl 2:S19-30.
18. Milligan GN, Dudley KL, Bourne N, Reece A, Stanberry LR. Entry of inflammatory cells into the mouse vagina following appllication of candidate microbicides. Sex Transmit Dis 2002;29:597-605.
19. Catalone BJ, Kish-Catalone TM, Budgeon LR, Neely EB, Ferguson M, Krebs FC, Howett MK, Labib M, Rando R, Wigdahl B. Mouse model of cervicovagina toxicyty and inflammation for preclinical evaluation of topical vaginal microbides. Antimicrob Agents Chemother 2004;48:1837-47. (Pubitemid 38544396)
20. Stanley MA. Immune responses to human papillomavirus. Vaccine 2006;24(suppl 1): S16-22.
21. Imarai M, Candia E, Rodriguez-Tirado C, Tognarelli J, Pardo M, Perez T, Valdes D, Reyes-Cerpa S, Nelson P, Acuna-Castillo C, Maisey K. Regulatory T cells are locally induced during intravaginal infection of mice with Neisseria gonorrhoeae. Infect Immun 2008;76:5456-65.
22. Makita S, Kanai T, Nemoto Y, Totsuka T, Okamoto R, Tsuchiya K, Yamamoto M, Kiyono H, Watanabe M. Intestinal lamina propria retaining CD4+CD25+ regulatory T cells is a suppressive site of intestinal inflammation. J Immunol 2007;178:4937-46. (Pubitemid 46595276)
23. Guo Z, Jang MH, Otani K, Bai Z, Umemoto E, Matsumoto M, Nishiyama M, Yamasaki M, Ueha S, Matsushima, Hirata T, Miyasaka. CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype. Int Immunol 2008;20:307-15.
24. Cao Y, Zhao J, Lei Z, Shen S, Liu C, Li D, Liu J, Shen G, Zhang GM, Feng Z, Huang B. Local accumulation of FOXP3+ regulatory T cells: evidence for an immune evasion mechanisms in patients with large condylomata acuminata. J Immunol 2008;180:7681-6.
25. Van der Burg SH, Piersma SJ, De Jong JH, Van der Hulst JM, Kwappenberg KMC, Van den Hende M, Welters MJP, Van Rood JJ, Fleuren GJ, Melief CJ, Kenter GG, Offringa R. Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens. Proc Natl Acad Sci USA 2007;104:12087-92. (Pubitemid 47185634)
26. Loddenkemper c, Hoffmann C, Stanke J, Nagorsen D, Baron U, Olek S, Huehn J, Ritz JP, Stein H, Kaufmann AM, Schneider A, Cichon G. Regulatory (FOXP3+)T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer. Cancer Sci 2009;100:112-1117.
27. Jaafar F, Righi E, Lindstrom V, Linton C, Nohadani M, Van Noorden S, Lloyd T, Poznansky J, Stamp G, Dina R, Coleman DV, Poznansky MC. Correlation of CXCL12 expression and FoxP3+ cell infiltration with Human Papillomavirus infection and clinicopathological progression of cervical caner. Am J Pathol 2009;175:1525-35.